v3.26.1
Consolidated Statements of Operations
€ in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2025
EUR (€)
€ / shares
shares
Dec. 31, 2024
EUR (€)
€ / shares
shares
Revenue € 149  
Cost of sales 92  
Gross margin 57  
Operating Expenses and Costs    
Selling and distribution expenses 877 € 678
General and administrative expenses 5,073 4,648
Research and development expenses 1,817 1,118
Gain on reconsolidation   (62,554)
Other Operating income (13) (398)
Total Operating Expenses and Costs 7,754 (56,508)
Income (Loss) from Operations (7,697) 56,508
Other Income (Expenses)    
Income from changes in fair value of convertible note payable carried at fair value 11,108 8,923
Gain / (Loss) on foreign currency translation 604 (405)
Total Other Income 11,712 8,518
Net Income € 4,015 € 65,026
Earnings Per Share [Abstract]    
Basic (in EUR per Share) | € / shares € 2.76 € 44.86
Diluted (in EUR per Share) | € / shares € 0.5 € 3.77
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]    
Basic (in shares) | shares 1,456,914 1,449,485
Diluted (in shares) | shares 8,034,644 17,254,895